478253-45-1(SALOR-INT L216828-1EA)

478253-45-1 Basic information More..

Product Name:	SALOR-INT L216828-1EA
Synonyms:	SALOR-INT L216828-1EA;7-[(2E)-3-CHLORO-2-BUTENYL]-1,3-DIMETHYL-8-((2E)-2-[1-(4-NITROPHENYL)ETHYLIDENE]HYDRAZINO)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE;1H-Purine-2,6-dione, 7-(3-chloro-2-buten-1-yl)-3,7-dihydro-1,3-dimethyl-8-[2-[1-(4-nitrophenyl)ethylidene]hydrazinyl]-
CAS:	478253-45-1
MF:	C19H20ClN7O4
MW:	445.86
EINECS:
Mol File:	Mol File

Information Error Report

Your Email:

Browse by Nationality 478253-45-1 Suppliers

Finland(2)

United States(1)

All(3)

478253-45-1 Recommend Suppliers

Recommend You Select Member Companies.

Company Name:	PHARMEKS Ltd. Recommend Complaint
Tel:	+7 (495) 702-9648
Email:	sales@pharmeks.com
Nationality:	Finland
Products Intro:	CAS:478253-45-1 Package:5μmol Remarks:C19H20ClN7O4
CB Index:	50
WebSite:	www.pharmeks.com
Related Information:	Sales Network Catalog(6343) User Evaluation

Company Name:	Interbioscreen Ltd. Recommend Complaint
Tel:	+7 (49) 6524-0091
Email:	screen@ibscreen.chg.ru
Nationality:	Finland
Products Intro:	CAS:478253-45-1 Purity:95% Package:1mg Remarks:C19H20ClN7O4
CB Index:	60
WebSite:	www.ibscreen.com
Related Information:	Sales Network Catalog(6169) User Evaluation

Company Name:	Riedel-de Haen AG Recommend Complaint
Tel:	800 558-9160
Email:
Nationality:	United States
Products Intro:
CB Index:	87
WebSite:	www.sigmaaldrich.com
Related Information:	Sales Network Catalog(6624) User Evaluation(11)

Tag: 478253-45-1

HomePage | About Us | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms
All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.